Lymphocyte Recovery Is a Major Determinant of Outcome after Matched Unrelated Myeloablative Transplantation for Myelogenous Malignancies
Open Access
- 1 September 2009
- journal article
- research article
- Published by Elsevier in Transplantation and Cellular Therapy
- Vol. 15 (9) , 1108-1115
Abstract
No abstract availableKeywords
This publication has 37 references indexed in Scilit:
- Absolute Lymphocyte Count on Day 30 Is a Surrogate for Robust Hematopoietic Recovery and Strongly Predicts Outcome after T Cell-Depleted Allogeneic Stem Cell TransplantationTransplantation and Cellular Therapy, 2007
- Transplantation of mesenchymal stem cells to enhance engraftment of hematopoietic stem cellsLeukemia, 2007
- Granulocyte and granulocyte-macrophage colony-stimulating factors in allografts: Uses, misuses, misconceptions, and future applicationsExperimental Hematology, 2005
- Treatment With Granulocyte Colony-Stimulating Factor After Allogeneic Bone Marrow Transplantation for Acute Leukemia Increases the Risk of Graft-Versus-Host Disease and Death: A Study From the Acute Leukemia Working Party of the European Group for Blood and Marrow TransplantationJournal of Clinical Oncology, 2004
- Effectiveness of Donor Natural Killer Cell Alloreactivity in Mismatched Hematopoietic TransplantsScience, 2002
- A prospective randomized trial of Filgrastim (r-metHuG-CSF) given at different times after unrelated bone marrow transplantationBone Marrow Transplantation, 1999
- A Proportional Hazards Model for the Subdistribution of a Competing RiskJournal of the American Statistical Association, 1999
- Management of graft‐versus‐host diseaseEuropean Journal of Haematology, 1993
- HLA‐DR typing by PCR amplification with sequence‐specific primers (PCR‐SSP) in 2 hours: An alternative to serological DR typing in clinical practice including donor‐recipient matching in cadaveric transplantationTissue Antigens, 1992
- Nonparametric Estimation from Incomplete ObservationsJournal of the American Statistical Association, 1958